SCHEMBL10475868

SCHEMBL10475868

CN(Cc1cccc(-c2cnc(N3CCC(N4CCOCC4)CC3)nc2)c1)C(=O)CNC(=O)O

nearest known ligand 0.80

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ AOC3 Q16853 20/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10318214 0.92 AOC3 (0.76) AOC3
SCHEMBL11363116 0.90 AOC3 (0.75) AOC3
SCHEMBL10318372 0.89 AOC3 (1.00) AOC3
SCHEMBL10317994 0.86 AOC3 (0.74) AOC3
SCHEMBL10318534 0.85 AOC3 (0.75) AOC3
SCHEMBL10475883 0.85 AOC3 (0.61) AOC3
SCHEMBL10317060 0.83 AOC3 (0.62) AOC3
SCHEMBL10317439 0.82 AOC3 (0.68) AOC3
SCHEMBL10318375 0.82 AOC3 (0.83) AOC3
SCHEMBL10317972 0.82 AOC3 (0.64) AOC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2479165-B1 GLYCINE COMPOUND ASTELLAS PHARMA INC (JP) 2017-10-25 — — EP disclosed
US-8802679-B2 Glycine compound ASTELLAS PHARMA INC. (JP) 2014-08-12 — — US disclosed
EP-2479165-A1 GLYCINE COMPOUND Astellas Pharma Inc. (JP) 2012-07-25 — — EP disclosed
Send feedback